AcquisitionOther
Medicus Pharma Ltd. acquired Antev Ltd.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Medicus Pharma Ltd. -> Antev Ltd. · US$65 Million
Acquire clinical-stage drug development company for Teverelix, a next generation GnRH antagonist for cardiovascular and prostate indications.
Open source record (SEC) ↗